‘Assessing the long-term impact of multimodality management of rectal cancer during the pandemic and beyond’

ReCaP will primarily describe the impact of the unprecedented COVID-19 pandemic on modern rectal cancer management. The pandemic will yield a unique cohort of patients whose rectal cancer has been managed in a novel way, and it is paramount that the long-term outcomes associated with such approaches are recognised and documented. Such approaches may prove to have longer term utility post COVID-19 if the oncological outcomes are favourable; however, there is only a brief window of opportunity to collect these patient data.

To register your site – EOI form Here.

Share this page